Journal Article Summary

This article investigates the potential effects of antipsychotic medications on breast tumors, particularly focusing on the risk of developing breast cancer. Antipsychotics are commonly prescribed for mental health disorders and can lead to increased levels of prolactin, a hormone linked to breast cancer risk. Understanding the relationship between these medications and breast tumors is crucial, as breast cancer is a leading cause of cancer-related death among women.

The researchers analyzed data from the Japanese Adverse Drug Event Report (JADER) database, focusing on reports related to women and breast tumors from 2004 to 2019. They looked for signals indicating a connection between antipsychotics and breast tumors, as well as hyperprolactinemia. While certain antipsychotics were associated with increased prolactin levels, the study found no evidence that these medications increased the risk of breast tumors. Additionally, laboratory experiments using breast cancer cells (MCF-7) showed that most antipsychotics did not promote cell growth, with blonanserin actually suppressing cell proliferation at higher concentrations.

Despite these findings, the study has limitations, including potential biases in the reporting database and a lack of detailed patient information. It is important for patients taking antipsychotics to discuss any concerns about breast cancer risk with their healthcare providers, especially if they have other risk factors. Further research is needed to fully understand the implications of these medications on breast cancer development and to explore the effects of blonanserin more comprehensively.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Maeshima Tae, Iijima Ryosuke, Watanabe Machiko, Yui Satoru, Itagaki Fumio. Effect of antipsychotics on breast tumors by analysis of the Japanese Adverse Drug Event Report database and cell-based experiments. Journal of Pharmaceutical Health Care and Sciences 2021. DOI: 10.1186/s40780-021-00199-7. PMID: 33789764. PMCID: PMC8015017.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]